Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 1 to 50 of 2439

TitleReference numberPublishedLast updated
Zolbetuximab with chemotherapy for untreated claudin-18.2-positive HER2-negative unresectable advanced gastric or gastro-oesophageal junction adenocarcinomaTA1046
Atezolizumab for untreated advanced or recurrent non-small-cell lung cancer when platinum-doublet chemotherapy is unsuitable (terminated appraisal)TA1047
Alcohol-mediated perivascular renal sympathetic denervation for resistant hypertensionIPG801
12 SQ-HDM SLIT for treating allergic rhinitis and allergic asthma caused by house dust mitesTA1045
Osimertinib for adjuvant treatment of EGFR mutation-positive non-small-cell lung cancer after complete tumour resectionTA1043
Exagamglogene autotemcel for treating severe sickle cell disease in people 12 years and overTA1044
Advanced breast cancer: diagnosis and treatmentCG81
Durvalumab with etoposide and either carboplatin or cisplatin for untreated extensive-stage small-cell lung cancerTA1041
Selpercatinib for previously treated RET fusion-positive advanced non-small-cell lung cancerTA1042
Early and locally advanced breast cancer: diagnosis and managementNG101
Ganaxolone for treating seizures caused by CDKL5 deficiency disorder in people 2 years and overTA1033
Selpercatinib for advanced thyroid cancer with RET alterations after treatment with a targeted cancer drug in people 12 years and overTA1038
Selpercatinib for advanced thyroid cancer with RET alterations untreated with a targeted cancer drug in people 12 years and overTA1039
Olaparib for treating BRCA mutation-positive HER2-negative advanced breast cancer after chemotherapyTA1040
Artificial intelligence-derived software to analyse chest X-rays for suspected lung cancer in primary care referrals: early value assessmentHTE12
Ovarian cancerQS18
Pembrolizumab for adjuvant treatment of resected non-small-cell lung cancerTA1037
Elacestrant for treating oestrogen receptor-positive HER2-negative advanced breast cancer with an ESR1 mutation after endocrine treatmentTA1036
Intravascular lithotripsy to treat calcified coronary arteries during percutaneous coronary interventionIPG802
Digital technologies to support self-management of COPD: early value assessmentHTE19
Tobacco: preventing uptake, promoting quitting and treating dependenceNG209
Epilepsies in children, young people and adultsNG217
Gambling-related harms: identification, assessment and managementNG248
Vadadustat for treating symptomatic anaemia in adults having dialysis for chronic kidney diseaseTA1035
Niraparib with abiraterone acetate and prednisone for untreated hormone-relapsed metastatic prostate cancer (terminated appraisal)TA1032
Anhydrous sodium thiosulfate for preventing hearing loss caused by cisplatin chemotherapy in people 1 month to 17 years with localised solid tumoursTA1034
Vamorolone for treating Duchenne muscular dystrophy in people 4 years and overTA1031
Bimekizumab for treating moderate to severe hidradenitis suppurativa (terminated appraisal)TA1028
Andexanet alfa for reversing anticoagulation in people with intracranial haemorrhage (terminated appraisal)TA1029
Durvalumab with chemotherapy before surgery (neoadjuvant) then alone after surgery (adjuvant) for treating resectable non-small-cell lung cancerTA1030
Andexanet alfa for reversing anticoagulation from apixaban or rivaroxabanTA697
Maternal and child nutrition: nutrition and weight management in pregnancy, and nutrition in children up to 5 yearsNG247
Artificial intelligence technologies to help detect fractures on X-rays in urgent care: early value assessmentHTE20
Digitally enabled therapies for adults with depression: early value assessmentHTE8
Overweight and obesity managementNG246
Electrically stimulated intravesical therapy for interstitial cystitis or overactive bladder in adultsIPG799
Tebentafusp for treating advanced uveal melanomaTA1027
Transperineal laser ablation for treating lower urinary tract symptoms of benign prostatic hyperplasiaIPG798
Tirzepatide for managing overweight and obesityTA1026
Home-testing devices for diagnosing obstructive sleep apnoea hypopnoea syndromeDG62
MRI-guided focused ultrasound thalamotomy for treating moderate to severe tremor in Parkinson'sIPG796
MRI-guided focused ultrasound subthalamotomy for treating Parkinson'sIPG797
Ublituximab for treating relapsing multiple sclerosisTA1025
Direct skeletal fixation of limb prostheses using an intraosseous transcutaneous implantIPG795
Urinary tract infection (recurrent): antimicrobial prescribingNG112
Elranatamab for treating relapsed and refractory multiple myeloma after 3 or more treatmentsTA1023
Toripalimab with chemotherapy for untreated advanced oesophageal squamous cell cancer (terminated appraisal)TA1024
Crizotinib for treating ROS1-positive advanced non-small-cell lung cancerTA1021
Bevacizumab gamma for treating wet age-related macular degenerationTA1022
Meningitis (bacterial) and meningococcal diseaseQS19

Results per page

  1. 10
  2. 25
  3. 50
  4. All